Tekla Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Tekla Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$12.3M	Hold	147,677	–	–	0.48%	51
2023 Q1	$11.3M	Hold	147,677	–	–	0.43%	52
2022 Q4	$12.3M	Hold	147,677	–	–	0.46%	52
2022 Q3	$11.7M	Sell	147,677 -61,477	-29%	-$5.18M	0.48%	50
2022 Q2	$15.5M	Buy	209,154 +113,505	+119%	+$8.52M	0.61%	43
2022 Q1	$8.6M	Buy	+95,649	New	+$8.83M	0.3%	70
2020 Q1	–	Sell	-68,037	Closed	-$6.47M	–	222
2019 Q4	$6.47M	Sell	68,037 -20,985	-24%	-$1.82M	0.24%	88
2019 Q3	$6.79M	Hold	89,022	–	–	0.3%	66
2019 Q2	$7.81M	Hold	89,022	–	–	0.32%	69
2019 Q1	$8.06M	Sell	89,022 -55,402	-38%	-$4.71M	0.33%	65
2018 Q4	$10.4M	Buy	144,424 +15,424	+12%	+$1.24M	0.44%	45
2018 Q3	$12.4M	Sell	129,000 -121,460	-48%	-$11.8M	0.45%	52
2018 Q2	$23.8M	Hold	250,460	–	–	0.9%	29
2018 Q1	$22M	Buy	250,460 +24,000	+11%	+$2.19M	0.85%	30
2017 Q4	$19.2M	Hold	226,460	–	–	0.74%	33
2017 Q3	$19.6M	Hold	226,460	–	–	0.7%	33
2017 Q2	$17.5M	Hold	226,460	–	–	0.65%	34
2017 Q1	$15.7M	Buy	226,460 +47,460	+27%	+$3.19M	0.61%	33
2016 Q4	$10.6M	Buy	+179,000	New	+$11M	0.45%	51
2016 Q3	–	Sell	-294,000	Closed	-$15.9M	–	154
2016 Q2	$15.9M	Hold	294,000	–	–	0.65%	35
2016 Q1	$15.2M	Buy	+294,000	New	+$15.3M	0.65%	35

Other funds holding XBI

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

APF

Alaska Permanent Fund Juneau, Alaska $1.57B AUM 15.23% 1-Year Est. Return

Tekla Capital Management's XBI Position: Q2 2023 in Review

Tekla Capital Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2023 at 147,677 shares worth $12.3M. The position accounts for 0.48% of the portfolio, ranked #51.

Tekla Capital Management first reported a position in XBI in Q1 2016 and has held it in 21 quarters since. The position peaked at $23.8M in Q2 2018. 713 funds tracked by Wall St. Rank hold XBI as of Q2 2023.

Tekla Capital Management held 147,677 shares of State Street SPDR S&P Biotech ETF worth $12.3M as of Q2 2023.
Tekla Capital Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2023.
State Street SPDR S&P Biotech ETF made up 0.48% of Tekla Capital Management's portfolio in Q2 2023, its #51 holding.
Tekla Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2016 and has held it in 21 quarters since.
Tekla Capital Management's State Street SPDR S&P Biotech ETF position peaked at $23.8M in Q2 2018.
713 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.